Cargando…
Elevated circulating miR-182 acts as a diagnostic biomarker for early colorectal cancer
PURPOSE: Globally, colorectal cancer (CRC) is one of the most common cancers with high mortality. Although CRC patients in stages I–II are curable after surgical resection, due to the lack of sensitive and specific biomarkers, many patients are in the advanced stages when diagnosed. This study aimed...
Autores principales: | Liu, Xiangxiang, Xu, Tao, Hu, Xiuxiu, Chen, XiaoXiang, Zeng, Kaixuan, Sun, Li, Wang, Shukui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5927061/ https://www.ncbi.nlm.nih.gov/pubmed/29731665 http://dx.doi.org/10.2147/CMAR.S158016 |
Ejemplares similares
-
Circulating miR-1290 and miR-320d as Novel Diagnostic Biomarkers of Human Colorectal Cancer
por: Liu, Xiangxiang, et al.
Publicado: (2019) -
CircHIPK3 promotes colorectal cancer growth and metastasis by sponging miR-7
por: Zeng, Kaixuan, et al.
Publicado: (2018) -
SP1-induced lncRNA-ZFAS1 contributes to colorectal cancer progression via the miR-150-5p/VEGFA axis
por: Chen, Xiaoxiang, et al.
Publicado: (2018) -
Circulating miR-182 is a biomarker of colorectal adenocarcinoma progression
por: Perilli, Lisa, et al.
Publicado: (2014) -
P53-induced miR-1249 inhibits tumor growth, metastasis, and angiogenesis by targeting VEGFA and HMGA2
por: Chen, Xiaoxiang, et al.
Publicado: (2019)